Ventral Hernias Clinical Trial
— CLOSE-GAPOfficial title:
The Clinical Effects of Intracorporally Closure of the Hernia Defect in Laparoscopic Umbilical or Epigastric Hernia Repair
NCT number | NCT01962480 |
Other study ID # | CLOSE-GAP-1 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2013 |
Est. completion date | February 2019 |
Verified date | February 2019 |
Source | Hvidovre University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Introduction: Closure of the hernia gap in laparoscopic ventral hernia repair before mesh
reinforcement has gained increasing acceptance among surgeons despite creating a
tension-based repair. Beneficial effects of this technique have sporadically been reported
but no evidence is available from randomized controlled trials.
The primary purpose is to compare early postoperative activity-related pain in patients
undergoing ventral hernia repair with closure of the gap with patients undergoing standard
laparoscopic ventral hernia repair (non-closure of the gap). Secondary outcomes are cosmesis
and hernia-related quality of life (QoL) at 30-days and clinical or radiological recurrence
and chronic pain after 2 years.
Material and Methods: A randomized, controlled, double-blinded study is planned. Based on
power calculation we will include 40 patients in each arm. Patients undergoing elective
laparoscopic umbilical, epigastric, or umbilical trocar-site hernia repair at Hvidovre
Hospital, Herlev Hospital, or Køge Hospital, who meet the inclusion criteria, are invited to
participate.
Conclusion: The technique with closure of the gap may induce more postoperative pain, but may
be superior with regard to other important surgical outcomes. No studies have previously
investigated closure of the gap in the setting of a randomised controlled trial.
Status | Completed |
Enrollment | 80 |
Est. completion date | February 2019 |
Est. primary completion date | August 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Inclusion criteria - Elective, primary or recurrent laparoscopic umbilical or epigastric hernia repair, umbilical trocar-site hernia and epigastric hernia repair where laparoscopic hernia repair is no contraindication (i.e. previous laparotomy with anticipated severe and dense adhesions - Hernia defect between 2-6 cm measured preoperatively by the surgeon at the out-patient clinic - Maximum 1 defect - Patients 18-80 years Patients with technical failure (where it is not possible to suture the defect) or patients who are reoperated due to complications remain included and will stay in their primary assigned randomization group in order to perform an intention to treat (ITT) analysis. Exclusion Criteria: - Open hernia repair - Poor compliance (language problems, dementia and alcohol or drug abuse etc.) - Fascia defect >6 cm (largest diameter, evaluated preoperatively and intra-operatively, thus patients are excluded if the defect is found larger intra-operatively) - Emergency repair - Chronic pain syndrome (chronic back pain, chronic headache, severe dysmenorrhea, fibromyalgia, whiplash or other conditions requiring daily opioid medication) - Daily consumption of opioids (for the last 3 weeks up till the operation) - Decompensated liver cirrhosis (Child-Pugh B-C) - If the hernia repair is secondarily to another surgical procedure - If a patient withdraws his/her inclusion consent |
Country | Name | City | State |
---|---|---|---|
Denmark | Hvidovre University Hospital | Hvidovre |
Lead Sponsor | Collaborator |
---|---|
Hvidovre University Hospital | University of Copenhagen |
Denmark,
Sauerland S, Walgenbach M, Habermalz B, Seiler CM, Miserez M. Laparoscopic versus open surgical techniques for ventral or incisional hernia repair. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007781. doi: 10.1002/14651858.CD007781.pub2. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Hernia-specific quality of life | Measured with Carolina Comfort Scale (CCS) | measured 30 days postoperatively | |
Other | complications, readmittance, and general practitioner visits | Measured with patient interview, and/or patient files | 30-days postoperatively | |
Other | clinical recurrence | clinical or radiological recurrence | 2 years | |
Other | chronic pain | moderate or severe chronic pain after 2 years | within 2 years | |
Primary | Pain at mobilisation from lying to sitting position measured with Visual Analogue Scale | 24 hrs postoperatively | ||
Secondary | Cosmetic result measured with verbal rating scale and numeric rating scales | measured 30 days postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01183325 -
Prospective Evaluation of the Proceed Ventral Patch With and Without Laparoscopic Evaluation
|
N/A | |
Completed |
NCT01673568 -
Abdominal Binder to Reduce Pain and Seroma Formation
|
N/A | |
Withdrawn |
NCT02730936 -
Antimicrobial Hernia Repair Device
|
N/A | |
Completed |
NCT01784822 -
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
|
N/A |